Sanofi

Sanofi is a healthcare firm that discovers, develops and distributes medicine, consumer healthcare products and other therapeutic solutions. Read more

57,876 Followers on Owler
57,876 Followers on Owler
57,876 Followers on Owler
57,876 Followers on Owler

Sanofi

Sanofi is a healthcare firm that discovers, develops and distributes medicine, consumer healthcare products and other therapeutic solutions. Read more

Paul Hudson's photo - CEO of Sanofi

CEO

Paul Hudson

CEO Approval Rating

65/100

Founded:

1994

Status:

PublicIndependent CompanyNYSESNY

SANOFI TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

TEVA is Sanofi's #1 competitor. TEVA's headquarters is in Petach Tikva, Center District, and was founded in 1901. Like Sanofi, TEVA also works within the Pharmaceuticals sector. TEVA generates 34% of Sanofi's revenue.

Sandoz is one of Sanofi's top rivals. Sandoz was founded in Holzkirchen, Bavaria} in 1886. Sandoz operates in the Pharmaceuticals industry. Compared to Sanofi, Sandoz generates $37.2B less revenue.

Mylan is one of Sanofi's top competitors. Mylan is a Private company that was founded in 1961 in Canonsburg, Pennsylvania. Mylan is in the Pharmaceuticals industry. Compared to Sanofi, Mylan has 71,859 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Abbott a competitor of Sanofi?

Sanofi Quarterly and Annual Revenue

Coming soon for Sanofi!

Annual Revenue

$46.8B

Sanofi's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 31.6B.

Sanofi Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Tidal Therapeutics

Apr 2021

Source »
$160M
-
Kymab Limited

Jan 2021

Source »
$1.1B
Kymab is a biotechnology firm that develops and commercializes human antibody-based therapeutics for the treatment of infectious diseases.
Kiadis Pharma N.V.

Nov 2020

Source »
$358.4M
Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer.
Principia Biopharma, Inc.

Aug 2020

Source »
$3.7B
Principia is a biopharmaceutical company that develops small molecule drugs for the treatment of immune-mediated diseases.
Synthorx, Inc.

Dec 2019

Source »
$2.5B
Synthorx develops and commercializes novel protein therapeutics for the treatment of cancer, immune-oncology and autoimmune disorders.

These are all the companies that Sanofi has acquired. Sanofi has acquired 11 companies and its latest acquisition was Tidal Therapeutics in Apr 2021.

Sanofi Funding History

No recent funding data found related to Sanofi

Sanofi Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Novadiscovery is a health tech platform that provides clinical trial simulation solutions for the development of new drugs and medical devices.
$3M
Feb 15, 2021
Series A
-
Jeito is a venture capital firm that invests in biopharmaceutical and biotechnology companies.
$59M
Nov 12, 2020
Investment Fund
-
Aetion develops a healthcare analytics platform that provides statistical medical insights for life sciences companies and regulatory agencies.
$27M
Feb 03, 2019
Series B
-
-
Oct 01, 2018
Equity
-
Thermalin is a biotechnology company that researches, develops and commercializes engineered insulin analogs for diabetic patients.
$17.5M
Sep 27, 2017
Series A
-

These are all the companies that Sanofi has invested in. Sanofi has invested 11 companies and its latest investment was Tidal Therapeutics in Apr 2021.

Sanofi News

May 4, 2021MarketScreener

Financial Report

(marketscreener.com) CORPORATE SOCIAL RESPONSIBILTY CHAPTER 4 OF 2020 DOCUMENT D'ENREGISTREMENT UNIVE... See more »
May 4, 2021MarketScreener

renewals, ratification of a co-opting Director and appointment of one new Director

(marketscreener.com) Board composition: renewals, ratification of a co-opting Director and appointmen... See more »
May 4, 2021Industrial Info Resources

Sanofi Offers Facilities to Rivals for COVID-19 Vaccines

SUGAR LAND--May 4, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Sanofi is offer... See more »
May 3, 2021Law 360

Sanofi Misled Buyers About Pain Relief Patches, Suit Says

A proposed class of consumers accused Sanofi US Corp. of misrepresenting the strength and longevity o... See more »
May 3, 2021MarketScreener

Goldman Sachs reiterates its Buy rating

(marketscreener.com) Keyur Parekh from Goldman Sachs retains his positive opinion on the stock with a... See more »
May 3, 2021Contract Pharma

Sanofi, Moderna Enter COVID-19 Vaccine Fill/Finish Manufacturing Deal

Sanofi will provide fill/finish services for up to 200 million doses of Moderna's COVID-19 vaccine in... See more »
April 30, 2021CompanyNews HQ

Annual General Meeting of April 30, 2021

Annual General Meeting of April 30, 2021 Approval of the financial statements for the fiscal year 202... See more »

Sanofi Blogs

Sanofi Press Releases

April 1, 2021centralcharts

Information concerning the total number of voting rights and shares - February 2021

Information concerning the total number of voting rights and shares, provided pursuant to article L. ... See more »
March 22, 2021Cision Canada

Sanofi Canada earns Gold-level gender parity certification for the second straight year

/CNW Telbec/ - Celebrating its second straight recognition by the Women in Governance organization, S... See more »
February 22, 2021centralcharts

Information concerning the total number of voting rights and shares - January 2021

Information concerning the total number of voting rights and shares, provided pursuant to article L. ... See more »
January 26, 2021GlobeNewswire

Information concerning the total number of voting rights and shares - December 2020

Information concerning the total number of voting rights and shares, provided pursuant to article L. ... See more »
December 18, 2020Cision Canada

Health Canada approves expanded indication for SOLIQUA

/CNW Telbec/ - Sanofi Canada announced that Health Canada has approved expanded use of SOLIQUA®. The ... See more »
December 18, 2020centralcharts

Mylan Wins Summary Judgment in EpiPen Litigation Brought by Sanofi

Mylan Wins Summary Judgment in EpiPen® Litigation Brought by Sanofi PR Newswire PITTSBURGH, Dec. 18, ... See more »
November 30, 2020GlobeNewswire

Informations relatives au nombre total de droits de vote et d'actions - Octobre 2020

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 ... See more »

Sanofi Videos

Social Media

Sanofi Headquarters

54, rue La Boetie

Paris, Île-de-France75008

33-1-53-77-40-00

Driving Directions »

Trending Companies

Sanofi Summary

ABOUT

Overview

Sanofi SA (EPA: SAN) is a healthcare company which discovers, develops and distributes therapeutic solutions focused on patients' needs. The French multinational pharmaceutical company was founded in 2004 and headquartered in Paris, France with 112,12...

CEO

Sanofi's CEO, Paul Hudson, currently has an approval rating of 65%. Sanofi's primary competitors are TEVA, Sandoz & Mylan.

Website

sanofi.com

Frequently Asked Questions about Sanofi

  1. When was Sanofi founded?

    Sanofi was founded in 1994
  2. Who is Sanofi's CEO?

    Sanofi's CEO is Paul Hudson
  3. How much revenue does Sanofi generate?

    Sanofi generates $46.8B in revenue
  4. How much funding does Sanofi have?

    Sanofi has historically raised $0 in funding
  5. Where is Sanofi's headquarters?

    Sanofi's headquarters is in Paris Île-de-France, FR
  1. How many employees does Sanofi have?

    Sanofi has 106,859 employees
  2. What sector does Sanofi operate in?

    Sanofi is in Pharmaceuticals
  3. Who are Sanofi's competitors?

    Sanofi's top competitors are TEVA, Sandoz, Mylan
  4. Who has Sanofi invested in?

    Sanofi's has invested in companies such as Novadiscovery, Jeito, Aetion